Mihalovic, M.; Mikulenka, P.; LÃnková, H.; Neuberg, M.; Å tÄ›tkářová, I.; Peisker, T.; Lauer, D.; Tousek, P.
Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) in Patients after Acute Stroke: Relation to Stroke Severity, Myocardial Injury, and Impact on Prognosis. J. Clin. Med. 2022, 11, 2552.
https://doi.org/10.3390/jcm11092552
AMA Style
Mihalovic M, Mikulenka P, LÃnková H, Neuberg M, Å tÄ›tkářová I, Peisker T, Lauer D, Tousek P.
Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) in Patients after Acute Stroke: Relation to Stroke Severity, Myocardial Injury, and Impact on Prognosis. Journal of Clinical Medicine. 2022; 11(9):2552.
https://doi.org/10.3390/jcm11092552
Chicago/Turabian Style
Mihalovic, Michal, Petr Mikulenka, Hana LÃnková, Marek Neuberg, Ivana Å tÄ›tkářová, Tomáš Peisker, David Lauer, and Petr Tousek.
2022. "Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) in Patients after Acute Stroke: Relation to Stroke Severity, Myocardial Injury, and Impact on Prognosis" Journal of Clinical Medicine 11, no. 9: 2552.
https://doi.org/10.3390/jcm11092552
APA Style
Mihalovic, M., Mikulenka, P., LÃnková, H., Neuberg, M., Å tÄ›tkářová, I., Peisker, T., Lauer, D., & Tousek, P.
(2022). Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) in Patients after Acute Stroke: Relation to Stroke Severity, Myocardial Injury, and Impact on Prognosis. Journal of Clinical Medicine, 11(9), 2552.
https://doi.org/10.3390/jcm11092552
